Advertisement

MR Imaging of Epithelial Ovarian Neoplasms Part II

Malignant

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Magnetic Resonance Imaging Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Siegel R.L.
        • Miller K.D.
        • Fuchs H.E.
        • et al.
        Cancer Statistics, 2021.
        CA: a Cancer J clinicians. 2021; 71: 7-33
        • Thomassin-Naggara I.
        • Bazot M.
        • Daraï E.
        • et al.
        Epithelial ovarian tumors: value of dynamic contrast-enhanced mr imaging and correlation with tumor angiogenesis.
        Radiology. 2008; 248: 148-159
        • Javadi S.
        • Ganeshan D.M.
        • Qayyum A.
        • et al.
        Ovarian Cancer, the Revised FIGO Staging System, and the Role of Imaging.
        AJR Am J roentgenology. 2016; 206: 1351-1360
        • Expert Panel on Women’s I.
        • Kang S.K.
        • Reinhold C.
        • et al.
        Acr appropriateness criteria® staging and follow-up of ovarian cancer.
        J Am Coll Radiol. 2018; 15: S198-S207
        • Masch W.R.
        • Daye D.
        • Lee S.I.
        MR Imaging for Incidental Adnexal Mass Characterization.
        Magn Reson Imaging Clin N Am. 2017; 25: 521-543
        • Chandrashekhara S.H.
        • Thulkar S.
        • Srivastava D.N.
        • et al.
        Pre-operative evaluation of peritoneal deposits using multidetector computed tomography in ovarian cancer.
        Br J Radiol. 2011; 84: 38-43
        • Rettenmaier N.B.
        • Rettenmaier C.R.
        • Wojciechowski T.
        • et al.
        The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary peritoneal carcinoma: a 16-year institutional review.
        Br J Cancer. 2010; 103: 1657-1662
        • Mutch D.G.
        • Prat J.
        2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer.
        Gynecol Oncol. 2014; 133: 401-404
        • Prat J.
        Staging classification for cancer of the ovary, fallopian tube, and peritoneum.
        Int J Gynaecol Obstet official Organ Int Fed Gynaecol Obstet. 2014; 124: 1-5
        • Tempany C.M.
        • Zou K.H.
        • Silverman S.G.
        • et al.
        Staging of advanced ovarian cancer: comparison of imaging modalities--report from the Radiological Diagnostic Oncology Group.
        Radiology. 2000; 215: 761-767
        • Atri M.
        • Alabousi A.
        • Reinhold C.
        • et al.
        ACR Appropriateness Criteria(®) Clinically Suspected Adnexal Mass, No Acute Symptoms.
        J Am Coll Radiol. 2019; 16: S77-S93
      1. Rendi MH. Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: histopathology. In: Post TW editor. UpToDate. UpToDate; 2021. Available at: https://www.uptodate.com/contents/epithelial-carcinoma-of-the-ovary-fallopian-tube-and-peritoneum-histopathology. Accessed July 3, 2021.

        • Bent C.L.
        • Sahdev A.
        • Rockall A.G.
        • et al.
        MRI appearances of borderline ovarian tumours.
        Clin Radiol. 2009; 64: 430-438
        • Shetty M.
        Imaging and differential diagnosis of ovarian cancer.
        Semin Ultrasound CT MR. 2019; 40: 302-318
        • Sohaib S.A.
        • Mills T.D.
        • Sahdev A.
        • et al.
        The role of magnetic resonance imaging and ultrasound in patients with adnexal masses.
        Clin Radiol. 2005; 60: 340-348
        • Iyer V.R.
        • Lee S.I.
        MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization.
        AJR Am J roentgenology. 2010; 194: 311-321
        • Tanaka Y.O.
        • Yoshizako T.
        • Nishida M.
        • et al.
        Ovarian carcinoma in patients with endometriosis: MR imaging findings.
        AJR Am J roentgenology. 2000; 175: 1423-1430
        • Davarpanah A.H.
        • Kambadakone A.
        • Holalkere N.S.
        • et al.
        Diffusion MRI of uterine and ovarian masses: identifying the benign lesions.
        Abdom Radiol. 2016; 41: 2466-2475
        • Zhao S.H.
        • Qiang J.W.
        • Zhang G.F.
        • et al.
        Diffusion-weighted MR imaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation.
        Eur Radiol. 2014; 24: 2292-2299
        • Jung S.E.
        • Lee J.M.
        • Rha S.E.
        • et al.
        Ct and mr imaging of ovarian tumors with emphasis on differential diagnosis.
        RadioGraphics. 2002; 22: 1305-1325
        • Foti P.V.
        • Attinà G.
        • Spadola S.
        • et al.
        MR imaging of ovarian masses: classification and differential diagnosis.
        Insights Imaging. 2016; 7: 21-41
        • Desai A.
        • Xu J.
        • Aysola K.
        • et al.
        Epithelial ovarian cancer: An overview.
        World J Transl Med. 2014; 3: 1-8
        • Elsherif S.
        • Javadi S.
        • Viswanathan C.
        • et al.
        Low-grade epithelial ovarian cancer: what a radiologist should know.
        BJR. 2019; 92: 20180571
        • Skírnisdóttir I.
        • Garmo H.
        • Wilander E.
        • et al.
        Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer.
        Int J Cancer. 2008; 123: 1897-1901
        • Bodurka D.C.
        • Deavers M.T.
        • Tian C.
        • et al.
        Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study.
        Cancer. 2012; 118: 3087-3094
        • Zeppernick F.
        • Meinhold-Heerlein I.
        The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer.
        Arch Gynecol Obstet. 2014; 290: 839-842
        • Meinhold-Heerlein I.
        • Fotopoulou C.
        • Harter P.
        • et al.
        The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications.
        Arch Gynecol Obstet. 2016; 293: 695-700
        • Nik N.N.
        • Vang R.
        • Shih Ie M.
        • et al.
        Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma.
        Annu Rev Pathol. 2014; 9: 27-45
        • Köbel M.
        • Kalloger S.E.
        • Huntsman D.G.
        • et al.
        Differences in tumor type in low-stage versus high-stage ovarian carcinomas.
        Int J Gynecol Pathol : official J Int Soc Gynecol Pathol. 2010; 29: 203-211
        • Turashvili G.
        • Lastra R.
        What's new in gynecologic pathology 2021: ovary and fallopian tube.
        J Pathol Translational Med. 2021; 55: 366-367
        • Kurman R.J.
        Origin and molecular pathogenesis of ovarian high-grade serous carcinoma.
        Ann Oncol : official J Eur Soc Med Oncol. 2013; 24: x16-x21
        • Ganeshan D.
        • Bhosale P.
        • Wei W.
        • et al.
        Increase in post-therapy tumor calcification on CT scan is not an indicator of response to therapy in low-grade serous ovarian cancer.
        Abdom Radiol. 2016; 41: 1589-1595
        • WHO Classification of Tumours Editorial Board
        Female genital tumours.
        International Agency for Research on Cancer, Lyon (France)2020 (WHO classification of tumours series, 5th edition.; vol. 4))
        • Ali R.H.
        • Seidman J.D.
        • Luk M.
        • et al.
        Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumor.
        Int J Gynecol Pathol : official J Int Soc Gynecol Pathol. 2012; 31: 499-506
        • Seidman J.D.
        • Kurman R.J.
        Pathology of ovarian carcinoma.
        Hematology/Oncology Clin North America. 2003; 17 (vii): 909-925
        • Mangili G.
        • Bergamini A.
        • Taccagni G.
        • et al.
        Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience.
        Gynecol Oncol. 2012; 126: 403-407
        • Duska L.R.
        • Garrett L.
        • Henretta M.
        • et al.
        When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes.
        Gynecol Oncol. 2010; 116: 374-377
        • Takahama J.
        • Ascher S.M.
        • Hirohashi S.
        • et al.
        Borderline Brenner tumor of the ovary: MRI findings.
        Abdom Imaging. 2004; 29: 528-530
        • Moon W.J.
        • Koh B.H.
        • Kim S.K.
        • et al.
        Brenner tumor of the ovary: CT and MR findings.
        J Comput Assist tomography. 2000; 24: 72-76
        • Takeuchi M.
        • Matsuzaki K.
        • Sano N.
        • et al.
        Malignant Brenner tumor with transition from benign to malignant components: computed tomographic and magnetic resonance imaging findings with pathological correlation.
        J Comput Assist tomography. 2008; 32: 553-554
        • Saida T.
        • Mori K.
        • Tanaka Y.O.
        • et al.
        Carcinosarcoma of the ovary: MR and clinical findings compared with high-grade serous carcinoma.
        Jpn J Radiol. 2021; 39: 357-366
        • Thomassin-Naggara I.
        • Aubert E.
        • Rockall A.
        • et al.
        Adnexal masses: development and preliminary validation of an MR imaging scoring system.
        Radiology. 2013; 267: 432-443
        • Basha M.A.A.
        • Abdelrahman H.M.
        • Metwally M.I.
        • et al.
        Validity and Reproducibility of the ADNEX MR Scoring System in the Diagnosis of Sonographically Indeterminate Adnexal Masses.
        J Magn Reson Imaging : JMRI. 2021; 53: 292-304
        • Reinhold C.
        • Rockall A.
        • Sadowski E.A.
        • et al.
        Ovarian-adnexal reporting lexicon for mri: a white paper of the acr ovarian-adnexal reporting and data systems mri committee.
        J Am Coll Radiol. 2021; 18: 713-729
        • Adusumilli S.
        • Hussain H.K.
        • Caoili E.M.
        • et al.
        MRI of sonographically indeterminate adnexal masses.
        AJR Am J roentgenology. 2006; 187: 732-740
        • Robboy S.J.
        • Scully R.E.
        Strumal carcinoid of the ovary: an analysis of 50 cases of a distinctive tumor composed of thyroid tissue and carcinoid.
        Cancer. 1980; 46: 2019-2034
        • Yamashita Y.
        • Hatanaka Y.
        • Takahashi M.
        • et al.
        Struma ovarii: MR appearances.
        Abdom Imaging. 1997; 22: 100-102
        • Park S.B.
        • Kim J.K.
        • Kim K.R.
        • et al.
        Imaging findings of complications and unusual manifestations of ovarian teratomas.
        RadioGraphics. 2008; 28: 969-983
        • Ghafoor S.
        • Lakhman Y.
        • Park K.J.
        • et al.
        Polypoid endometriosis: a mimic of malignancy.
        Abdom Radiol. 2020; 45: 1776-1782
        • Mansour S.M.
        • Saraya S.
        • El-Faissal Y.
        Semi-quantitative contrast-enhanced MR analysis of indeterminate ovarian tumours: when to say malignancy?.
        Br J Radiol. 2015; 88: 20150099
        • McDermott S.
        • Oei T.N.
        • Iyer V.R.
        • et al.
        MR imaging of malignancies arising in endometriomas and extraovarian endometriosis.
        RadioGraphics. 2012; 32: 845-863